Open-label study of efgartigimod in seronegative myasthenia gravis
Authors
- Mohamed Khateb (ORCID: https://orcid.org/0000-0002-2262-2674)
- Leif E. Lovblom (ORCID: https://orcid.org/0000-0002-6774-8924)
- Ajith Sivadasan (ORCID: https://orcid.org/0000-0001-9949-7878)
- Hans Katzberg (ORCID: https://orcid.org/0000-0002-4716-3304)
- Carolina Barnett‐Tapia
- Lubna Daniyal
- Vera Bril (ORCID: https://orcid.org/0000-0002-5805-4883)
- Shiyi Chen (ORCID: https://orcid.org/0000-0001-9190-3122)
- Lahiru Fernando
Institutions
- University Health Network (CA)
- University of Toronto (CA)
Publication Details
- Journal
- Therapeutic Advances in Neurological Disorders
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1177/17562864251388019
- Primary Topic
- Myasthenia Gravis and Thymoma
- Type
- article
- Field-Weighted Citation Impact
- 0.00